Nifty
:
22604.85
Sensex
:
74482.78
-38.55 (-0.17%)
-188.50 (-0.25%)
Nifty
Sensex
:
:
22604.85
74482.78
-38.55 (-0.17%)
-188.50 (-0.25%)

Bharat Parenterals Ltd.

Pharmaceuticals & Drugs

Rating :
70/99

BSE: 541096 | NSE: Not Listed

NSE BSE
1701.65
30-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1791.20
  •  1824.70
  •  1701.65
  •  1791.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  253
  •  222.98
  •  1824.70
  •  321.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 990.30
  • 57.38
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,036.02
  • 0.04%
  • 5.00

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.27%
  • 8.43%
  • 13.61%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 4.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.73
  • 9.19
  • -2.42

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.05
  • 18.12
  • 0.19

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.03
  • 18.21
  • -4.46

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 10.09
  • 11.44

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 1.50
  • 1.56

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 6.94
  • 8.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
59.82
59.02
1.36%
59.80
81.90
-26.98%
69.91
26.09
167.96%
50.97
52.31
-2.56%
Expenses
53.21
56.37
-5.61%
55.48
72.71
-23.70%
59.46
24.28
144.89%
44.75
47.91
-6.60%
EBITDA
6.61
2.65
149.43%
4.32
9.19
-52.99%
10.45
1.81
477.35%
6.22
4.40
41.36%
EBIDTM
11.05%
4.49%
7.22%
11.22%
14.95%
6.94%
12.20%
8.41%
Other Income
1.26
3.48
-63.79%
2.60
6.41
-59.44%
2.10
1.54
36.36%
0.31
2.19
-85.84%
Interest
0.58
0.79
-26.58%
0.63
0.34
85.29%
0.89
0.25
256.00%
0.80
0.31
158.06%
Depreciation
1.82
1.44
26.39%
1.75
1.46
19.86%
1.58
1.54
2.60%
1.44
1.56
-7.69%
PBT
5.47
3.90
40.26%
4.54
13.80
-67.10%
10.08
1.56
546.15%
4.29
4.72
-9.11%
Tax
1.83
1.43
27.97%
2.11
3.96
-46.72%
3.07
0.44
597.73%
2.02
0.75
169.33%
PAT
3.64
2.47
47.37%
2.43
9.84
-75.30%
7.01
1.12
525.89%
2.27
3.97
-42.82%
PATM
6.08%
4.18%
4.06%
12.01%
10.03%
4.29%
4.45%
7.59%
EPS
6.55
4.94
32.59%
6.05
17.18
-64.78%
13.03
2.05
535.61%
4.23
7.00
-39.57%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
240.50
212.01
204.64
228.18
219.54
136.58
111.44
124.11
Net Sales Growth
9.66%
3.60%
-10.32%
3.94%
60.74%
22.56%
-10.21%
 
Cost Of Goods Sold
144.13
136.07
134.27
148.91
140.48
88.18
79.07
83.01
Gross Profit
96.37
75.95
70.38
79.26
79.06
48.39
32.37
41.10
GP Margin
40.07%
35.82%
34.39%
34.74%
36.01%
35.43%
29.05%
33.12%
Total Expenditure
212.90
184.10
179.40
200.53
190.69
124.44
104.98
114.12
Power & Fuel Cost
-
3.21
3.10
3.19
2.70
2.62
1.79
2.06
% Of Sales
-
1.51%
1.51%
1.40%
1.23%
1.92%
1.61%
1.66%
Employee Cost
-
15.37
14.75
15.58
15.37
12.94
11.37
9.10
% Of Sales
-
7.25%
7.21%
6.83%
7.00%
9.47%
10.20%
7.33%
Manufacturing Exp.
-
8.43
7.35
8.60
9.12
5.01
4.07
3.78
% Of Sales
-
3.98%
3.59%
3.77%
4.15%
3.67%
3.65%
3.05%
General & Admin Exp.
-
3.09
2.53
2.88
3.47
1.91
1.46
4.54
% Of Sales
-
1.46%
1.24%
1.26%
1.58%
1.40%
1.31%
3.66%
Selling & Distn. Exp.
-
7.72
7.30
12.04
13.62
9.50
4.47
10.22
% Of Sales
-
3.64%
3.57%
5.28%
6.20%
6.96%
4.01%
8.23%
Miscellaneous Exp.
-
10.21
10.10
9.34
5.93
4.27
2.74
1.42
% Of Sales
-
4.82%
4.94%
4.09%
2.70%
3.13%
2.46%
1.14%
EBITDA
27.60
27.91
25.24
27.65
28.85
12.14
6.46
9.99
EBITDA Margin
11.48%
13.16%
12.33%
12.12%
13.14%
8.89%
5.80%
8.05%
Other Income
6.27
7.93
8.68
11.90
12.74
7.17
7.71
5.05
Interest
2.90
1.31
0.77
0.86
0.87
0.94
0.91
1.49
Depreciation
6.59
6.66
6.03
5.88
6.13
5.57
5.79
4.20
PBT
24.38
27.88
27.12
32.80
34.59
12.79
7.48
9.35
Tax
9.03
7.06
6.81
8.65
13.35
3.68
0.59
2.89
Tax Rate
37.04%
25.32%
25.11%
26.37%
38.59%
28.77%
7.89%
30.91%
PAT
15.35
21.05
20.39
24.14
21.25
9.12
6.89
6.45
PAT before Minority Interest
17.26
20.81
20.32
24.14
21.25
9.12
6.89
6.45
Minority Interest
1.91
0.24
0.07
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.38%
9.93%
9.96%
10.58%
9.68%
6.68%
6.18%
5.20%
PAT Growth
-11.78%
3.24%
-15.53%
13.60%
133.00%
32.37%
6.82%
 
EPS
26.47
36.29
35.16
41.62
36.64
15.72
11.88
11.12

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
165.83
143.87
118.19
94.01
72.85
63.68
56.69
Share Capital
5.77
5.73
5.73
5.73
5.73
5.73
5.73
Total Reserves
160.05
137.71
112.46
88.28
67.12
57.95
50.96
Non-Current Liabilities
14.38
11.21
3.42
4.42
0.22
3.29
7.39
Secured Loans
9.75
8.59
0.71
0.97
2.34
3.67
6.57
Unsecured Loans
2.74
0.00
0.00
0.00
0.00
0.34
0.33
Long Term Provisions
0.94
0.64
0.51
0.09
0.08
0.00
0.00
Current Liabilities
41.53
43.63
65.88
60.51
56.88
42.79
56.18
Trade Payables
23.76
26.17
42.61
31.91
26.56
36.37
38.84
Other Current Liabilities
13.00
15.42
22.60
25.93
22.22
6.22
0.37
Short Term Borrowings
2.78
1.19
0.00
1.95
4.98
0.00
12.53
Short Term Provisions
1.99
0.84
0.67
0.71
3.13
0.21
4.44
Total Liabilities
226.06
198.66
187.49
158.94
129.95
109.76
120.26
Net Block
39.75
43.36
31.75
33.98
33.71
31.16
34.69
Gross Block
72.98
71.05
53.58
50.12
44.11
35.99
62.47
Accumulated Depreciation
33.22
27.69
21.83
16.14
10.40
4.83
27.78
Non Current Assets
82.32
50.63
55.88
40.91
39.12
45.78
48.64
Capital Work in Progress
25.65
0.44
12.16
1.06
0.00
0.00
0.00
Non Current Investment
0.00
0.00
1.31
1.36
0.00
0.55
0.50
Long Term Loans & Adv.
13.49
2.77
7.93
1.95
2.85
9.71
9.30
Other Non Current Assets
2.34
2.86
2.73
2.56
2.57
4.35
4.15
Current Assets
143.74
148.02
131.62
118.02
90.83
63.98
71.62
Current Investments
11.48
42.79
0.01
1.47
0.52
0.00
0.00
Inventories
20.76
22.43
28.82
22.52
14.43
15.27
14.12
Sundry Debtors
73.40
67.83
79.35
63.87
58.65
43.60
44.06
Cash & Bank
4.68
2.43
10.40
12.13
4.13
1.58
12.74
Other Current Assets
33.41
0.45
0.45
0.51
13.10
3.53
0.69
Short Term Loans & Adv.
31.71
12.09
12.59
17.52
12.57
0.20
0.12
Net Current Assets
102.20
104.40
65.74
57.51
33.94
21.20
15.44
Total Assets
226.06
198.65
187.50
158.93
129.95
109.76
120.26

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-1.07
24.45
14.45
20.43
6.34
-2.11
0.00
PBT
27.88
27.12
32.80
34.59
12.79
7.48
0.00
Adjustment
4.85
10.37
6.23
6.63
6.27
5.88
0.00
Changes in Working Capital
-28.13
-6.37
-14.53
-10.36
-10.17
-13.88
0.00
Cash after chg. in Working capital
4.60
31.12
24.50
30.87
8.89
-0.52
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-5.67
-6.68
-10.04
-10.44
-2.56
-1.59
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-6.63
-43.37
-12.60
-9.35
-8.07
-1.53
0.00
Net Fixed Assets
-2.55
-5.31
-14.56
-7.07
-8.12
26.48
Net Investments
25.52
-40.25
1.51
-2.31
0.03
-0.30
Others
-29.60
2.19
0.45
0.03
0.02
-27.71
Cash from Financing Activity
9.42
10.50
-2.82
-3.89
4.04
-7.52
0.00
Net Cash Inflow / Outflow
1.72
-8.43
-0.96
7.18
2.30
-11.16
0.00
Opening Cash & Equivalents
1.68
10.10
11.07
3.88
1.58
12.74
0.00
Closing Cash & Equivalent
3.40
1.68
10.10
11.07
3.88
1.58
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
287.16
250.34
206.27
164.07
127.14
111.14
98.95
ROA
9.80%
10.52%
13.94%
14.71%
7.61%
5.99%
5.37%
ROE
13.46%
15.53%
22.76%
25.47%
13.35%
11.45%
11.38%
ROCE
17.18%
20.24%
30.83%
39.30%
18.10%
11.47%
14.23%
Fixed Asset Turnover
3.35
3.80
4.40
4.66
3.46
2.41
2.10
Receivable days
106.98
113.54
114.55
101.85
134.69
134.78
122.67
Inventory Days
32.72
39.53
41.06
30.72
39.13
45.19
39.31
Payable days
66.97
93.48
91.33
56.53
92.40
126.93
125.22
Cash Conversion Cycle
72.73
59.59
64.28
76.03
81.42
53.04
36.75
Total Debt/Equity
0.11
0.09
0.01
0.05
0.12
0.10
0.34
Interest Cover
22.35
36.44
38.93
40.77
14.60
9.26
7.29

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Bharat Parenterals’ arm signs deal with two Global Complex Generic marketing companies
    13th Mar 2024, 12:46 PM

    According to agreement, Innoxel Lifesciences will receive cumulative milestone payments of Rs 31 crore over the period of next three years

    Read More
  • Bharat Parenterals - Quarterly Results
    13th Feb 2024, 12:25 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.